Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-033425

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Catherine M. Szyman
Officer — CVP, Critical Care & Vascular
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 12, 2016A2,750$0.00A34,570D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F4,F3$105.59May 12, 2016A25,200AMay 12, 2017May 11, 2023Common Stock25,20025,200D
Performance RightsF5,F4—May 12, 2016A3,425A——Common Stock3,4253,425D

Explanation of responses